ZA899533B - Medication for the treatment or prevention of hiv-virus infection through passive immunization and processes for its preparation - Google Patents
Medication for the treatment or prevention of hiv-virus infection through passive immunization and processes for its preparationInfo
- Publication number
- ZA899533B ZA899533B ZA899533A ZA899533A ZA899533B ZA 899533 B ZA899533 B ZA 899533B ZA 899533 A ZA899533 A ZA 899533A ZA 899533 A ZA899533 A ZA 899533A ZA 899533 B ZA899533 B ZA 899533B
- Authority
- ZA
- South Africa
- Prior art keywords
- hiv
- preparation
- prevention
- processes
- treatment
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 108010074605 gamma-Globulins Proteins 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Drug for the treatment or prevention by passive immunization of the HIV-infection and processes for preparation thereof. According to the invention, the drug consists of, or comprises, a preparation of anti-HIV gammaglobulins Ig6 and/or IgM of human origin without antibodies directed against glycoproteins of the HIV virus envelope and/or anti-CD4 antibodies.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8816580A FR2640511B1 (en) | 1988-12-15 | 1988-12-15 | MEDICINES FOR THE TREATMENT OR PREVENTION BY PASSIVE IMMUNIZATION OF HIV VIRUS INFECTION AND METHOD OF PREPARATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA899533B true ZA899533B (en) | 1990-12-28 |
Family
ID=9373004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA899533A ZA899533B (en) | 1988-12-15 | 1989-12-13 | Medication for the treatment or prevention of hiv-virus infection through passive immunization and processes for its preparation |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0374053B1 (en) |
| JP (1) | JPH03505738A (en) |
| CN (1) | CN1045035A (en) |
| AT (1) | ATE102836T1 (en) |
| AU (1) | AU627540B2 (en) |
| CA (1) | CA2005365C (en) |
| DE (1) | DE68913932T2 (en) |
| DK (1) | DK192990A (en) |
| ES (1) | ES2062079T3 (en) |
| FR (1) | FR2640511B1 (en) |
| IE (1) | IE63831B1 (en) |
| WO (1) | WO1990006773A1 (en) |
| ZA (1) | ZA899533B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE244888T1 (en) * | 1993-02-05 | 2003-07-15 | Epigen Inc | HUMAN CARCINOMA ANTIGEN (HCA), HCA ANTIBODIES, HCA IMMUNOASSAYS, RECORDING METHODS AND THERAPY |
| CN106110422B (en) * | 2016-07-01 | 2019-02-01 | 翁炳焕 | AIDS immunization therapy absorber |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604947A1 (en) * | 1986-02-17 | 1987-08-20 | Biotest Pharma Gmbh | METHOD FOR PRODUCING AN IMMUNALLOBULIN-CONTAINING PREPARATE AND THE USE THEREOF FOR PROPHYLAXIS AND THERAPY OF AIDS |
| US4863730A (en) * | 1986-03-21 | 1989-09-05 | Cenfold Holdings, S.A. | Immunotherapy for AIDS patients |
| KR970003056B1 (en) * | 1987-08-11 | 1997-03-14 | 존 에프. 투엔트 | Hyper-immune globulin against hiv |
-
1988
- 1988-12-15 FR FR8816580A patent/FR2640511B1/en not_active Expired - Fee Related
-
1989
- 1989-12-13 CA CA002005365A patent/CA2005365C/en not_active Expired - Fee Related
- 1989-12-13 ZA ZA899533A patent/ZA899533B/en unknown
- 1989-12-14 IE IE400589A patent/IE63831B1/en not_active IP Right Cessation
- 1989-12-15 EP EP89403495A patent/EP0374053B1/en not_active Expired - Lifetime
- 1989-12-15 JP JP2501084A patent/JPH03505738A/en active Pending
- 1989-12-15 AU AU48062/90A patent/AU627540B2/en not_active Ceased
- 1989-12-15 ES ES89403495T patent/ES2062079T3/en not_active Expired - Lifetime
- 1989-12-15 WO PCT/FR1989/000656 patent/WO1990006773A1/en unknown
- 1989-12-15 CN CN89109300A patent/CN1045035A/en active Pending
- 1989-12-15 DE DE68913932T patent/DE68913932T2/en not_active Expired - Fee Related
- 1989-12-15 AT AT89403495T patent/ATE102836T1/en not_active IP Right Cessation
-
1990
- 1990-08-14 DK DK192990A patent/DK192990A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE894005L (en) | 1990-06-15 |
| ES2062079T3 (en) | 1994-12-16 |
| CA2005365C (en) | 1995-12-12 |
| DK192990D0 (en) | 1990-08-14 |
| DE68913932T2 (en) | 1994-07-07 |
| JPH03505738A (en) | 1991-12-12 |
| WO1990006773A1 (en) | 1990-06-28 |
| ATE102836T1 (en) | 1994-04-15 |
| FR2640511A1 (en) | 1990-06-22 |
| EP0374053B1 (en) | 1994-03-16 |
| CA2005365A1 (en) | 1990-06-15 |
| AU627540B2 (en) | 1992-08-27 |
| DE68913932D1 (en) | 1994-04-21 |
| EP0374053A1 (en) | 1990-06-20 |
| FR2640511B1 (en) | 1993-04-23 |
| IE63831B1 (en) | 1995-06-14 |
| CN1045035A (en) | 1990-09-05 |
| DK192990A (en) | 1990-08-14 |
| AU4806290A (en) | 1990-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ335612A (en) | A composition containing cytotoxic specificT-cell epitopes being either Rev and/or Tat proteins from HIV virus for prevention and treatment of human immunodeficiency virus (HIV) infection | |
| EP0726758A4 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
| CA2192512A1 (en) | Nm03 antibody materials and methods | |
| EP0687182A4 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
| EP0230574A3 (en) | Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof | |
| HK1067958A1 (en) | Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells | |
| DK422589D0 (en) | PHARMACEUTICAL PREPARATION FOR TREATMENT OF IMMUNE DEFECTIVE CONDITIONS | |
| AU8010791A (en) | Hiv monoclonal antibody | |
| NO943653D0 (en) | Recombinant human HIV neutralizing monoclonal antibodies for prevention and treatment of HIV infection | |
| ZA899533B (en) | Medication for the treatment or prevention of hiv-virus infection through passive immunization and processes for its preparation | |
| DE69213325D1 (en) | Immune preparation directed against the human immunodeficiency virus | |
| AU5061090A (en) | Aids therapy | |
| CA2160696A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
| FR2614025B1 (en) | PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS | |
| CA2156416A1 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
| RU2003125554A (en) | NATURAL ANTIBODIES ACTIVE AGAINST HUMAN IMMUNODEFICIENCY VIRUS (HIV) | |
| FR2610632B1 (en) | CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS |